Researchers are exploring the use of patient-derived organoids in cancer research, which may help understand tumor biology and develop personalized treatments. Organoids are being studied in various types of cancer, including bladder, lung, and breast cancer, as well as malignant mesothelioma. The use of organoids in cancer research is seen as a promising tool, but also presents challenges that need to be addressed.